Kelsey Huntington

8PUBLICATIONS
34CO-AUTHORS
Molecular targetsGene and molecular therapyChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2026
ONC201 in combination with ATR inhibitor ceralasertib exhibits potent synergy in ovarian cancer cells.

|Feb 26, 2025
Modulation of blood-tumor barrier transcriptional programs improves intratumoral drug delivery and potentiates chemotherapy in GBM.

Jorge L Jimenez-Macias, Philippa Vaughn-Beaucaire, Ayush Bharati

|Nov 24, 2023
Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer.

Tej Tummala, Ashley Sanchez Sevilla Uruchurtu, Arielle De La Cruz

|Jul 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer.

Kelsey E Huntington, Anna D Louie, Praveen R Srinivasan

|Jan 17, 2023
Timing and cell specificity of senescence drives postnatal lung development and injury.

Hongwei Yao, Joselynn Wallace, Abigail L Peterson

|May 28, 2022
Integrin/TGF-β1 Inhibitor GLPG-0187 Blocks SARS-CoV-2 Delta and Omicron Pseudovirus Infection of Airway Epithelial Cells In Vitro, Which Could Attenuate Disease Severity.

Kelsey E Huntington, Lindsey Carlsen, Eui-Young So

Pageof 2

Frequent Collaborators

5 joint publications

Wafik S El-Deiry

2 joint publications

Lindsey Carlsen

2 joint publications

Benedito A Carneiro

1 joint publications

Anna D Louie